September 28, 2022 – BD officially opened the BD Innovation Center in collaboration with University of Maryland BioPark, offering University of Maryland, Baltimore (UMB) students and researchers access to state-of-the-art equipment to support and accelerate innovation in medical diagnostic technology.
Located in West Baltimore at the UM BioPark (part of the UMB campus), the BD Innovation Center goal is to help streamline clinical laboratory workflows and improve patient care by expanding basic diagnostic knowledge, developing new diagnostic capabilities and shaping the future of diagnostics by allowing students and researchers to provide real-world feedback on early diagnostic concepts.
The BD Innovation Center currently houses:
- The BD COR™ PX/GX fully automated high-throughput diagnostic system, which uses robotics and sample management software algorithms for infectious disease molecular testing;
- The BD MAX™ System for mid-throughput molecular applications, which includes a variety of clinically validated assays and an open system for sample-to-answer assay development;
- The BD BACTEC™ FX for state-of-the-art blood culture detection of organisms; and
- The BD Phoenix™ M50 for ID/AST providing sample-to-answer identification and antimicrobial susceptibility determinations.
The BD Integrated Diagnostic Solutions (IDS) business unit has its global headquarters in Sparks, Maryland with more than 2,200 associates responsible for developing and manufacturing the latest diagnostic technology solutions critical to identifying known and new pathogens. The site is integral to the company’s testing innovations around cervical cancer, respiratory infections, SARS-CoV-2 (COVID-19) as well as the ongoing fight against antimicrobial resistance.